Adequan Canine is a PSGAG disease-modifying osteoarthritis drug (DMOAD) formulated for intramuscular use in dogs. Each mL delivers 100 mg of polysulfated glycosaminoglycan to support canine joint health and is recommended for the treatment of non-infectious degenerative and/or traumatic arthritis and associated lameness of canine synovial joints. This veterinarian-prescribed dog joint support injection comes in a convenient 2 x 5 mL multiple-dose vial pack. Designed for veterinary joint care for dogs, it includes benzyl alcohol as a preservative and water for injection.